CA25821-5A - 0x0000000000003A1D

Males & Females of Non-Childbearing Potential

* Stipend may pay up to reflected amount.
Start Date: 
March 13, 2019 - 6:00am
End Date: 
March 23, 2019 - 9:30am
Study Number: CA25821
Group Number: 5A
Study Requirement: Healthy Normal Female
Stipend: $2,000.00
Screening Stipend: $0.00

Study Criteria:

  • Age: 18 - 55
  • BMI: 18 - 32
  • Weight Restriction: minimum weight 122 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat a condition in which the heart muscle becomes abnormally thick.
  • Route of Administration: Oral
  • Blood Draws: 22

Study Schedule:

  • Schedule Type: Short stays with returns
  • Study Length: One - 5 Night Stay & 1 Return

Screening Dates:

Event Day Event Date Site
Monday 2/18/2019 Phoenix
Wednesday 2/20/2019 Phoenix
Thursday 2/21/2019 Phoenix
Saturday 2/23/2019 Phoenix

Doctor Exam Dates:

Event Day Event Date Site
Thursday 2/28/2019 Phoenix
Monday 3/4/2019 Phoenix

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Wednesday 3/13/2019 6:00:00 AM Monday 3/18/2019 9:45:00 AM 1 Phoenix
Return Saturday 3/23/2019 7:45:00 AM Saturday 3/23/2019 9:30:00 AM 1 Phoenix